Skip to content
Penn Center for Innovation
Menu
Search
Close
Inventors
Disclose Your Invention
Commercializing Innovation
Entrepreneurs
PCI Startup Portfolio
PCI Ventures
Penn I-Corps
Penn and Greater Philadelphia’s Entrepreneurial Ecosystem & Resources
Partners
Search Penn Technologies
Corporate Alliances
Licensing
Partner with PCI
About
Contact PCI
Events
News
Metrics and Reports
PCI Fellows Program
Who We Are
Home
Treatment of cancer by inhibition of Blimp-1 (PRDM1) in the setting of gene-modified T cell therapy
Skip to content
Open toolbar
Accessibility Tools
Accessibility Tools
Increase Text
Increase Text
Decrease Text
Decrease Text
Grayscale
Grayscale
High Contrast
High Contrast
Negative Contrast
Negative Contrast
Light Background
Light Background
Links Underline
Links Underline
Readable Font
Readable Font
Reset
Reset